Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fatty Liver Alliance is a Canadian non-profit organization dedicated to raising awareness about the risks, causes, and prevention of life-threatening liver diseases, specifically Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH). The organization provides resources for patients and healthcare providers, advocates for better screening and diagnostic tools, and collaborates with stakeholders to improve liver health outcomes. It serves as a central hub for education and support for those affected by fatty liver disease in Canada and internationally through its advocacy and outreach programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fatty Liver Alliance.